Patient Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Blood Glucose Monitoring Systems, Cardiac Monitoring Devices), By End-use (Hospitals, Ambulatory Surgery Centers, Home Care Settings), By Region, And Segment Forecasts, 202

Patient Monitoring Devices Market Summary

The global patient monitoring devices market size was estimated at USD 54.33 billion in 2025 and is expected to reach USD 118.21 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. The expansion of industry can be attributed to the increasing demand for monitoring devices that measure, record, and display various biometric data, including blood pressure, temperature, and blood oxygen saturation levels.

The growing geriatric population, rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders, and the increasing need for continuous monitoring are key drivers supporting market growth. For instance, the World Health Organization estimates that by 2030, one in six people globally will be 60 years or older, amplifying the demand for technologies that enable timely intervention and remote care. Rising adoption of telehealth and remote patient monitoring programs driven by healthcare cost pressures and staffing shortages. For instance, the AMA Digital Health Care 2022 study highlighted that 93% of physicians find digital tools beneficial, with remote patient monitoring (RPM) usage more than doubling to 30% since 2016. This growing adoption reflects strong clinician confidence in connected monitoring devices for managing chronic diseases, post-acute recovery, and preventive care.

Technological developments in miniaturization, battery life, and wireless connectivity are further driving the market. For instance, in The FDA has cleared Dexcom’s G7 15-Day Continuous Glucose Monitoring (CGM) system for adults with diabetes. This next-generation device offers up to 15.5 days of wear time, improved accuracy with an 8.0% MARD, and a 12-hour grace period, making it the longest-lasting and most precise CGM currently available in the U.S. market. Similarly, in September 2022, Medtronic announced the FDA clearance of its LINQ II insertable cardiac monitor with Bluetooth connectivity, offering real-time arrhythmia data transmission to physicians and facilitating earlier intervention. These innovations highlight how continuous improvements in device design and connectivity are enhancing remote monitoring capabilities and supporting proactive chronic disease management.

Despite the positive outlook, challenges remain, such as data security concerns and reimbursement gaps for certain remote monitoring services. However, with continuous innovation, growing acceptance by clinicians, and value-based care models emphasizing preventive health management, the patient monitoring devices market is poised to witness robust growth over the forecast period.

Global Patient Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global patient monitoring devices market report based on product, end-use, and regions.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Blood Glucose Monitoring Systems
• Self-monitoring Blood Glucose Systems
• Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
• ECG Devices
• Implantable Loop Recorders
• Event Monitors
• Mobile Cardiac Telemetry Monitors
• Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices.
• Low-acuity Monitoring Devices
• Mid-acuity Monitoring Devices
• High-acuity Monitoring Devices
• Respiratory Monitoring Devices
• Pulse Oximeters
• Spirometers
• Capnographs
• Peak Flow Meters
• Temperature Monitoring Devices
• Handheld Temperature Monitoring Devices
• Table-top Temperature Monitoring Devices
• Wearable Continuous Monitoring Devices
• Invasive Temperature Monitoring Devices
• Smart Temperature Monitoring Devices
• Hemodynamic/Pressure Monitoring Devices
• Hemodynamic Monitors
• Blood Pressure Monitors
• Disposables
• Fetal & Neonatal Monitoring Devices
• Fetal Monitoring Devices
• Neonatal Monitoring Devices
• Neuromonitoring Devices
• Electroencephalograph Machines
• Electromyography Machines
• Cerebral Oximeters
• Intracranial Pressure Monitors
• Magnetoencephalograph Machines
• Transcranial Doppler Machines
• Weight Monitoring Devices
• Digital
• Analog
• Wearable Drug Delivery Systems
• Other Patient Monitoring Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more